Oysters could help combat antibiotic resistance
The mollusk shows infection-fighting capabilities
![Photo collage of an oyster with a blood bag on an IV drip](https://cdn.mos.cms.futurecdn.net/GXq7Cs96ThnLQ5ZtH9g2Hg-1280-80.jpg)
The answer to fighting a growing number of superbugs may be in the water. Researchers in Australia have pinpointed a protein found in oysters as a way to make antibiotics more effective. As infections rise and become harder to fight, finding new sources of antimicrobials will be more important than ever.
Breaking bacteria shells
Oysters contain an antimicrobial protein in their liquid that is similar to blood, according to a new study published in the journal PLOS One. This protein, called hemolymph, was found by researchers to be "effective at killing the bacteria Streptococcus pneumoniae, which mainly causes pneumonia, and Streptococcus pyogenes, the culprit for strep throat and scarlet fever," although it has not yet been tested on humans and animals, said The Guardian. The protein was discovered in the Sydney rock oyster (Saccostrea glomerata), native to Australia and New Zealand.
Many bacteria, like S. pneumoniae, are able to evade antibiotics by forming a "biofilm," or a community of "microorganisms that attach themselves to surfaces in a sticky, protective matrix," said Popular Science. Hemolymph was effective at killing the bacteria on its own, and "when paired up with antibiotics, the protein also helped improve their effectiveness against other infection-causing bacteria," said Smithsonian Magazine. Scientists believe the protein is successful because it disrupts the bacteria's biofilm. The protein was also found to be non-toxic to human lung cells.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Since the majority of antibiotics used today — as well as those currently in development — come from natural sources, scientists are always on the hunt for new sources. "Most organisms have natural defense mechanisms to protect themselves against infection," Kirsten Benkendorff, a marine scientist at Australia's Southern Cross University and the study coauthor, said in a statement. "Oysters are constantly filtering bacteria from the water, so they are a good place to look for potential antibiotics."
The world is our oyster
Antibiotic resistance has become a growing problem in public health. Bacteria are becoming more resistant due to the high number of infections, especially of the respiratory tract, and the overuse of antibiotics to treat them. This has led the microorganisms to evolve into stronger superbugs. Coupled with the ability to form a biofilm, infections are becoming much harder to kill. A 2024 study predicted that by 2050, approximately 2 million people, mostly 70 and over, could die from drug-resistant infections each year. "Because of this, new antibiotic treatments that can inhibit, disrupt or penetrate biofilms are very valuable," said Benkendorff and Kate Summer, another coauthor of the PLOS One study, at The Conversation.
While hemolymph shows promise, "more work is needed, including testing in animals and clinical human trials," said Benkendorff and Summer. "Sustainable supply of the proteins for research and medical use is an important consideration, but this is helped by the fact [that] Sydney rock oysters are commercially available." This research also presents an opportunity for collaboration between the pharmaceutical and aquaculture industries. "Given the significant costs in developing new medicines, the idea of using excess and/or imperfect oysters to generate a sustainable supply of antimicrobial proteins" should be "investigated further," Branwen Morgan, a researcher at Australia's Commonwealth Scientific and Industrial Research Organization, said to The Guardian.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
A running list of Marjorie Taylor Greene's controversies
In Depth Exploring the Georgia Republican's long history of incendiary behavior
By David Faris Published
-
What can Democrats do to oppose Trump?
Talking Points The minority party gets off to a 'slow start' in opposition
By Joel Mathis, The Week US Published
-
What product prices could tariffs affect?
The Explainer President Trump's tariff plan may raise the cost of food, gas, pharmaceuticals and more
By Becca Stanek, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Sperm cells can carry past trauma in their DNA
Under the radar Your parent's past may be affecting your future
By Devika Rao, The Week US Published
-
IVM is a better treatment than IVF for some people
The Explainer A less painful, less costly option for treating infertility emerges
By Theara Coleman, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published